551 related articles for article (PubMed ID: 27932342)
21. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.
Valderhaug TG; Jenssen T; Hartmann A; Midtvedt K; Holdaas H; Reisaeter AV; Hjelmesaeth J
Transplantation; 2009 Aug; 88(3):429-34. PubMed ID: 19667949
[TBL] [Abstract][Full Text] [Related]
22. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
Hage C; Lundman P; Rydén L; Mellbin L
Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
[TBL] [Abstract][Full Text] [Related]
23. Comparing HbA1c, fasting and 2-h plasma glucose for screening for abnormal glucose regulation in patients undergoing coronary angiography.
Wang JS; Lee IT; Lee WJ; Lin SY; Fu CP; Lee WL; Liang KW; Sheu WH
Clin Chem Lab Med; 2015 Aug; 53(9):1441-9. PubMed ID: 25405720
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the new fasting plasma glucose cutpoint of 7.0 mmol/l in detection of diabetes mellitus in the Thai population.
Nitiyanant W; Ploybutr S; Sriussadaporn S; Yamwong P; Vannasaeng S
Diabetes Res Clin Pract; 1998 Sep; 41(3):171-6. PubMed ID: 9829345
[TBL] [Abstract][Full Text] [Related]
25. Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin.
Yates CJ; Fourlanos S; Colman PG; Cohney SJ
Transplantation; 2013 Oct; 96(8):726-31. PubMed ID: 23902993
[TBL] [Abstract][Full Text] [Related]
26. Glycated haemoglobin threshold for dysglycaemia screening, and application to metabolic syndrome diagnosis in HIV-infected Africans.
Nguyen KA; Peer N; de Villiers A; Mukasa B; Matsha TE; Mills EJ; Kengne AP
PLoS One; 2019; 14(1):e0211483. PubMed ID: 30703147
[TBL] [Abstract][Full Text] [Related]
27. The importance of a postpartum 75 g oral glucose tolerance test in women with gestational diabetes.
Reinblatt SL; Morin L; Meltzer SJ
J Obstet Gynaecol Can; 2006 Aug; 28(8):690-694. PubMed ID: 17022908
[TBL] [Abstract][Full Text] [Related]
28. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.
Ko GT; Chan JC; Tsang LW; Cockram CS
Diabetes Care; 2000 Dec; 23(12):1770-3. PubMed ID: 11128350
[TBL] [Abstract][Full Text] [Related]
29. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
Gołembiewska E
Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
[TBL] [Abstract][Full Text] [Related]
30. Performance of HbA1c and fasting plasma glucose in screening for diabetes in patients undergoing coronary angiography.
Wang JS; Lee IT; Lee WJ; Lin SY; Fu CP; Ting CT; Lee WL; Liang KW; Sheu WH
Diabetes Care; 2013 May; 36(5):1138-40. PubMed ID: 23238660
[TBL] [Abstract][Full Text] [Related]
31. Hemoglobin A1c in predicting progression to diabetes.
Nakagami T; Tajima N; Oizumi T; Karasawa S; Wada K; Kameda W; Susa S; Kato T; Daimon M
Diabetes Res Clin Pract; 2010 Jan; 87(1):126-31. PubMed ID: 19945760
[TBL] [Abstract][Full Text] [Related]
32. Statistical Analysis on Threshold of Haemoglobin A1C (HBA1c) for Diabetes Diagnosis and the Relationship Between HBA1c and Plasma Glucose Concentrations in Chinese Diabetic High-Risk Groups.
Li X; Bao C; Zhao Y; Song H; Wang W
Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868839
[TBL] [Abstract][Full Text] [Related]
33. A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.
Cosson E; Hamo-Tchatchouang E; Banu I; Nguyen MT; Chiheb S; Ba H; Valensi P
Diabetes Metab; 2010 Sep; 36(4):312-8. PubMed ID: 20627649
[TBL] [Abstract][Full Text] [Related]
34. Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?
Sargeant LA; Boyne MS; Bennett FI; Forrester TE; Cooper RS; Wilks RJ
Rev Panam Salud Publica; 2004 Jul; 16(1):35-42. PubMed ID: 15333264
[TBL] [Abstract][Full Text] [Related]
35. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616
[TBL] [Abstract][Full Text] [Related]
36. Does HbA1C predict isolated impaired fasting glycaemia in the oral glucose tolerance test in subjects with impaired fasting glycaemia?
Likhari T; Aulakh TS; Singh BM; Gama R
Ann Clin Biochem; 2008 Jul; 45(Pt 4):418-20. PubMed ID: 18583629
[TBL] [Abstract][Full Text] [Related]
37. A Comparison of hs-CRP Levels in New Diabetes Groups Diagnosed Based on FPG, 2-hPG, or HbA1c Criteria.
Tutuncu Y; Satman I; Celik S; Dinccag N; Karsidag K; Telci A; Genc S; Issever H; Tuomilehto J; Omer B
J Diabetes Res; 2016; 2016():5827041. PubMed ID: 26824043
[TBL] [Abstract][Full Text] [Related]
38. Newly diagnosed diabetes based on an oral glucose tolerance test predicts cardiovascular outcomes in patients with coronary artery disease: An observational study.
Chen WL; Sheu WH; Li YH; Wang JS; Lee WJ; Liang KW; Lee WL; Lee IT
Medicine (Baltimore); 2022 Jul; 101(28):e29557. PubMed ID: 35839026
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of 1-hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes-related complications: A post hoc analysis of the 30-year follow-up of the Da Qing IGT and Diabetes Study.
Peng M; He S; Wang J; An Y; Qian X; Zhang B; Zhang L; Chen B; Yang Z; Li G; Gong Q;
Diabetes Obes Metab; 2024 Jun; 26(6):2329-2338. PubMed ID: 38488254
[TBL] [Abstract][Full Text] [Related]
40. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population.
Badings EA; Dyal L; Schoterman L; Lok DJ; Stoel I; Gerding MN; Gerstein HC; Tijssen JG
J Diabetes; 2011 Sep; 3(3):232-7. PubMed ID: 21631894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
